The Globe and Mail11d
Nonalcoholic Steatohepatitis Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies
DelveInsight’s, “Nonalcoholic Steatohepatitis Pipeline Insight” report provides comprehensive insights about 80+ companies and 80+ pipeline drugs in Nonalcoholic Steatohepatitis pipeline ...
manilatimes3d
PathAI Announces EMA Qualification for AIM-MASH AI Assist, a Groundbreaking AI Tool for MASH Clinical Trials
The EMA CHMP has determined that the proposed Artificial Intelligence-Based Measurement of Non-alcoholic Steatohepatitis Histology (AIM-MASH) tool can be used in metabolic dysfunction associated ...
U.S. News & World Report4d
EU Health Regulator Clears Use of AI Tool in Fatty Liver Disease Trials
The condition, called metabolic dysfunction-associated steatohepatitis, or MASH, is a difficult-to-treat disease that affects around 1.5% to 6.5% of adults in the U.S., according to the American ...
manilatimes6d
A New Standard in Clinical Care for MASH Patients: HistoIndex Launches FibroSIGHT™
This marks a significant milestone for HistoIndex as the company enters clinical care for patients with Metabolic Dysfunction-Associated Steatohepatitis (MASH). "I am excited to see how our core ...
Medscape9d
Nonalcoholic Steatohepatitis
Nonalcoholic steatohepatitis (NASH) is the progressive form of liver injury that carries a risk for progressive fibrosis, cirrhosis, and end-stage liver disease. Hepatocellular carcinoma (HCC ...
Nature6d
Non-alcoholic steatohepatitis articles from across Nature Portfolio
Non-alcoholic steatohepatitis (NASH) is a condition characterized by accumulation of fat, inflammation and injury in liver cells in people who consume little or no alcohol. It is the progressive ...
U.S. News & World Report3d
The Best Political Cartoons on Congress
Your trusted source for the latest news delivered weekdays from the team at U.S. News and World Report. Sign in to manage your newsletters » Sign up to receive the latest updates from U.S News ...
pharmaphorum10d
The growing challenge of conducting clinical trials for metabolic associated steatohepatitis (MASH)
including metabolic associated steatohepatitis (MASH). But these researchers are facing a mounting pile of challenges when it comes to conducting their clinical trials, partly because of ...
The Denver Post16d
Homeland Security ends collective bargaining agreement with TSA staffers
WASHINGTON (AP) — The Department of Homeland Security said Friday that it is ending the collective bargaining agreement with the tens of thousands of frontline employees at the Transportation ...
The Mirror9d
Spandau Ballet fans predict reunion after Gary Kemp shares 'best news' in shock post
Fans think that Spandau Ballet could treat us all to an unexpected reunion after a couple of the members revealed that they’d been spending time together. On Instagram on March 13, guitarist ...
The Mirror8d
Sir Jim Ratcliffe names manager Manchester United should never have appointed
Manchester United head honcho Sir Jim Ratcliffe has named the one manager that the club should never have appointed. Since Sir Alex Ferguson retired in 2013 - having led the club to a 13th Premier ...